- Supported exchanges /
- STU /
- EZ1.STU
ENZON PHARM (EZ1.SG) (EZ1 STU) stock market data APIs
Enzon Pharmaceuticals, Inc., together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
ENZON PHARM (EZ1.SG) Financial Data Overview
| 0.0595 | |
| 0.0575 | |
| - | |
| 0.0595 | |
| 0.0575 | |
| 0.0465-0.182 | |
| 5 036 K | |
| 0 | |
| 74 215 K | |
| 26 000 | |
| 0.483 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ENZON PHARM (EZ1.SG) Fundamental Data is available in our Financial Data APIs
- Net Revenue 26 000
- EBITDA 0
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get ENZON PHARM (EZ1.SG) Earnings via APIs
- Latest Release 2024-11-07
- EPS/Forecast NaN
Get ENZON PHARM (EZ1.SG) End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
